Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori

Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori

Abstract Background Helicobacter pylori (HP) infection is associated with reduced lung function and systemic inflammation in chronic obstructive pulmonary disease (COPD) patients. Azithromycin (AZ) is active against HP and reduces the risk of COPD exacerbation. We determined whether HP infection sta...

Full description

Bibliographic Details
Main Authors: Seung Won Ra, Marc A. Sze, Eun Chong Lee, Sheena Tam, Yeni Oh, Nick Fishbane, Gerard J. Criner, Prescott G. Woodruff, Stephen C. Lazarus, Richard Albert, John E. Connett, Meilan K. Han, Fernando J. Martinez, Shawn D. Aaron, Robert M. Reed, S. F. Paul Man, Don D. Sin, on behalf of the Canadian Respiratory Research Network
Format: Article
Language:English
Published: BMC 2017-05-01
Series:Respiratory Research
Subjects:
Helicobacter pylori
COPD
Exacerbation
Azithromycin
Online Access:http://link.springer.com/article/10.1186/s12931-017-0594-x

Internet

http://link.springer.com/article/10.1186/s12931-017-0594-x

Similar Items